Target intelligence / Profile preview

V-type proton ATPase subunit c (ATP6V0C)

Target
ATP6V0C
Molecular classification
Enzyme, Transporter, Proton pump, V-type ATPase
01

Overview

V-type proton ATPase subunit c, encoded by the ATP6V0C gene, is a highly conserved 16 kDa proteolipid that forms the essential c-ring of the V0 rotary sector in the vacuolar-type H+-ATPase (V-ATPase) complex. This enzyme complex utilizes the energy from ATP hydrolysis to pump protons across biological membranes, a process vital for acidifying intracellular compartments such as lysosomes, endosomes, and secretory vesicles (UniProt P27449). Proper acidification is necessary for diverse cellular processes, including receptor-mediated endocytosis, protein sorting, and the activation of lysosomal hydrolases. In pathological contexts, ATP6V0C is often upregulated in various cancers, where it facilitates an acidic tumor microenvironment that promotes protease activation, extracellular matrix degradation, and epithelial-mesenchymal transition (PubMed: 28651546). Furthermore, it is a key mediator in bone resorption by osteoclasts and serves as a gateway for the entry of pH-dependent viruses into host cells (PubMed: 33053377). While potent inhibitors like bafilomycin A1 and concanamycin A are widely used in research to block ATP6V0C-mediated proton transport, their high toxicity has limited clinical application, prompting the search for more selective or tissue-specific V-ATPase modulators (PubMed: 25635393).

Other names
V-type proton ATPase 16 kDa proteolipid subunitVacuolar proton pump subunit cATP6CATP6LVPPCV-ATPase subunit c
02

Mechanism of action

Inhibition of the V0 sector of the V-type ATPase complex, which blocks the translocation of protons across membranes and prevents the acidification of intracellular compartments such as lysosomes and endosomes.

03

Biological functions

Proton transportIntracellular acidificationpH homeostasisAutophagyProtein degradationNeurotransmitter loadingEndocytosis
04

Disease associations

CancerOsteoporosisInfectionNeurodegenerative disease
05

Safety considerations

Systemic toxicity due to ubiquitous expressionImpaired lysosomal function in healthy tissuesPotential for osteopetrosis-like effectsDisruption of neurotransmitter storage and releasePotential hepatotoxicity
06

Interacting drugs

Bafilomycin A1

5 more in the full profile.

07

Biomarkers

Lysosomal pHCathepsin D activityATP6V0C mRNA expression levelsExtracellular pH

Beyond the preview

Go deeper on V-type proton ATPase subunit c (ATP6V0C).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on V-type proton ATPase subunit c (ATP6V0C).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call